{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2747, 
        2758
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2665, 
        2675
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2731, 
        2745
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3092, 
        3115
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2377, 
        2404
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        513, 
        542
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2122, 
        2148
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2153, 
        2161
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2181, 
        2189
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2208, 
        2216
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2236, 
        2244
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2265, 
        2273
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2348, 
        2356
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2513, 
        2522
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2721, 
        2730
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2992, 
        3007
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3038, 
        3047
      ]
    }
  ], 
  "Positive Findings Phraseology (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2650, 
        2664
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2170, 
        2177
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2198, 
        2204
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2225, 
        2232
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2282, 
        2289
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2310, 
        2316
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2337, 
        2344
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2421, 
        2431
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2433, 
        2442
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2586, 
        2596
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2917, 
        2926
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2150, 
        2152
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2317, 
        2318
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2572, 
        2573
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2679, 
        2680
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2902, 
        2905
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 2^9999^MOH|PIMS|CCO|201605041309|2AA4D9E70FB64FE2A527C1CCFCD9DD4DFAB1138F|ORU^R01|PIMS-OUT.1.125980|P|2.5|\nPID|1||9999999^^^^CMR^HOSPITAL 3&9999&MOH~9999999^^^^MRN^HOSPITAL 3&9999&MOH~9999999999&RT&ON^^^^JHN||XXXXXX^XXXXXXX^X^^^||99999999|M|||999 XXXXXXXXX XXXXXXXX^^XXXXXXXXX^XX^X9X 9X9^999|||||||||||||||||||N|\nOBR|1||16:S6889|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160426|||51108^XXXXXXX^XXXX^X.^^^||||||||||||20160504|||F|||||||99999^XXXXXXX^XXXX^^^^|\n\n\n\n\n\n\n\nPath report.gross description\n\nRichard Carter - U# 0832444 - specimen (1) labelled \"right base medial lateral\"\nconsists of two portions of pale tan soft tissue, 0.4 and 0.6 cm in length. \nEntirely submitted in cassette (1).\n \n   Richard Carter - U# 0832444 - specimen (2) labelled \"right mid medial lateral\"\nconsists of three cylindrical portions of white tan soft tissue, ranging from 0.5 to\n1.4 cm in length. Entirely submitted in cassette (2).\n \n   Richard Carter - U# 0832444 - specimen (3) labelled \"right apex\" consists of a\n1.3 cm long cylindrical portion of white tan soft tissue and a 0.1 cm scanty\nfragment. Entirely submitted in cassette (3).\n \n   Richard Carter - U# 0832444 - specimen (4) labelled \"right transitional zone\"\nand consists of a 1.7 cm long cylindrical portion of white tan soft tissue. \nEntirely submitted in cassette (4).\n \n   Richard Carter - U# 0832444 - specimen (5) labelled \"left base medial lateral\"\nconsists of a 1.5 cm long cylindrical portion of white tan soft tissue. Entirely\nsubmitted in cassette (5).\n \n   Richard Carter - U# 0832444 - specimen (6) labelled \"left mid medial lateral\"\nconsists of a 1.5 cm long cylindrical portion of white tan soft tissue. Entirely\nsubmitted in cassette (6).\n \n   Richard Carter - U# 0832444 - specimen (7) labelled \"left apex\" consists of a\n1.2 cm long cylindrical portion of white tan soft tissue. Entirely submitted in\ncassette (7).\n \n   Richard Carter - U# 0832444 - specimen (8) labelled \"left transitional zone\"\nconsists of a 1.7 cm long cylindrical portion of white tan soft tissue. Entirely\nsubmitted in cassette (8).\nMST/dl\n\n\nPath report.site of origin\n\n1: PROSTATE BIOPSY, Rt base\n2: PROSTATE BIOPSY, Rt mid\n3: PROSTATE BIOPSY, Rt apex\n4: PROSTATE BIOPSY, Rt trans\n5: PROSTATE BIOPSY, Lt base\n6: PROSTATE BIOPSY, Lt mid\n7: PROSTATE BIOPSY, Lt apex\n8: PROSTATE BIOPSY, Lt trans.\n\n\nPath report.final diagnosis\n\n1,2. PROSTATE (RIGHT BASE, RIGHT MID), BIOPSIES:\n   -  THREE NEEDLE CORE BIOPSIES, NEGATIVE FOR HIGH GRADE PROSTATIC\n     INTRAEPITHELIAL NEOPLASIA AND MALIGNANCY.\n \n3.  PROSTATE (RIGHT APEX), BIOPSY:\n   -  ATYPICAL SMALL ACINAR PROLIFERATION, SUSPICIOUS FOR MALIGNANCY.\n \n4.  PROSTATE (RIGHT TRANS), BIOPSY:\n   -  PROSTATIC ADENOCARCINOMA, ACINAR TYPE.\n     --  Gleason grade 7 (3+4) involving 15% of the single core submitted.\n     --  Gleason pattern 4 involves 30% of the malignant glands.\n \n5-8. PROSTATE (LEFT BASE, MID, APEX, TRANS), BIOPSIES:\n   -  FIVE NEEDLE CORE BIOPSIES OF PROSTATE TISSUE; NEGATIVE FOR HIGH GRADE\n     PROSTATIC INTRAEPITHELIAL NEOPLASIA AND MALIGNANCY.\n\n\nPath report.relevant Hx\n\nR/O CA\n8.82\n68 y/o man on active surveillance for CA prostate - PDA increased to 8.82 - for\nrepeat saturation biopsies\n\n\n"
}